Cybille Delacroix Muirhei

Array ( [id] => 7326528 [patent_doc_number] => 20040253139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Environmental surface disinfectant' [patent_app_type] => new [patent_app_number] => 10/461003 [patent_app_country] => US [patent_app_date] => 2003-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1772 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253139.pdf [firstpage_image] =>[orig_patent_app_number] => 10461003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664559 [patent_doc_number] => 20030203885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Cholesterol and hedgehog signaling' [patent_app_type] => new [patent_app_number] => 10/441857 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11519 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203885.pdf [firstpage_image] =>[orig_patent_app_number] => 10441857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6640677 [patent_doc_number] => 20030212123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'COX-2 selective carprofen for treating pain and inflammation in dogs' [patent_app_type] => new [patent_app_number] => 10/422220 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29499 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212123.pdf [firstpage_image] =>[orig_patent_app_number] => 10422220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805480 [patent_doc_number] => 20030232874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Methods and compositions for the treatment of chronic lymphocytic leukemia' [patent_app_type] => new [patent_app_number] => 10/404943 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6485 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232874.pdf [firstpage_image] =>[orig_patent_app_number] => 10404943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822168 [patent_doc_number] => 20030220329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Method of improving beta-adrenergic receptor function' [patent_app_type] => new [patent_app_number] => 10/394666 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6239 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220329.pdf [firstpage_image] =>[orig_patent_app_number] => 10394666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1101992 [patent_doc_number] => 06815450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'Axon regeneration with PKC inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/389082 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7307 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815450.pdf [firstpage_image] =>[orig_patent_app_number] => 10389082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691053 [patent_doc_number] => 07074807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Compositions and methods for inducing cell death' [patent_app_type] => utility [patent_app_number] => 10/382317 [patent_app_country] => US [patent_app_date] => 2003-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 51 [patent_no_of_words] => 11651 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074807.pdf [firstpage_image] =>[orig_patent_app_number] => 10382317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822075 [patent_doc_number] => 20030220236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Cyclic peptide antifungal agents and process for preparation thereof' [patent_app_type] => new [patent_app_number] => 10/378004 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10383 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220236.pdf [firstpage_image] =>[orig_patent_app_number] => 10378004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711543 [patent_doc_number] => 20030171292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Method for using lipoprotein associated coagulation inhibitor to treat sepsis' [patent_app_type] => new [patent_app_number] => 10/368000 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21315 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171292.pdf [firstpage_image] =>[orig_patent_app_number] => 10368000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404153 [patent_doc_number] => 20040023961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Aryl ureas with raf kinase and angiogenisis inhibiting activity' [patent_app_type] => new [patent_app_number] => 10/361844 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25853 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023961.pdf [firstpage_image] =>[orig_patent_app_number] => 10361844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852128 [patent_doc_number] => 20030144331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'p53 inhibitors and therapeutic use of the same' [patent_app_type] => new [patent_app_number] => 10/350560 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11093 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144331.pdf [firstpage_image] =>[orig_patent_app_number] => 10350560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829328 [patent_doc_number] => 20030180386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Aqueous metal bicarbonate solution and method of use' [patent_app_type] => new [patent_app_number] => 10/347284 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26464 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180386.pdf [firstpage_image] =>[orig_patent_app_number] => 10347284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729605 [patent_doc_number] => 20030185795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Oral delivery of chemically modified proteins' [patent_app_type] => new [patent_app_number] => 10/345639 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16569 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185795.pdf [firstpage_image] =>[orig_patent_app_number] => 10345639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765312 [patent_doc_number] => 20030099710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Granule modulating hydrogel system' [patent_app_type] => new [patent_app_number] => 10/335767 [patent_app_country] => US [patent_app_date] => 2003-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2189 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099710.pdf [firstpage_image] =>[orig_patent_app_number] => 10335767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674606 [patent_doc_number] => 20040127512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Method of treating symptoms of non-constipated irritable bowel syndrome' [patent_app_type] => new [patent_app_number] => 10/334170 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2019 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127512.pdf [firstpage_image] =>[orig_patent_app_number] => 10334170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674567 [patent_doc_number] => 20040127551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Taxane-based compositions and methods of use' [patent_app_type] => new [patent_app_number] => 10/330804 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12512 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127551.pdf [firstpage_image] =>[orig_patent_app_number] => 10330804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697309 [patent_doc_number] => 20030109503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics' [patent_app_type] => new [patent_app_number] => 10/321875 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4155 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109503.pdf [firstpage_image] =>[orig_patent_app_number] => 10321875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678911 [patent_doc_number] => 20030229052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Aqueous ifosfamide composition' [patent_app_type] => new [patent_app_number] => 10/319377 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3152 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229052.pdf [firstpage_image] =>[orig_patent_app_number] => 10319377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136297 [patent_doc_number] => 20040044005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Nicotine addiction treatment' [patent_app_type] => new [patent_app_number] => 10/310152 [patent_app_country] => US [patent_app_date] => 2002-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6589 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044005.pdf [firstpage_image] =>[orig_patent_app_number] => 10310152 [rel_patent_id] =>[rel_patent_doc_number] =>)